Malaysian Genomics Resource Centre Berhad 0155.KL Stock
Malaysian Genomics Resource Centre Berhad Price Chart
Malaysian Genomics Resource Centre Berhad 0155.KL Financial and Trading Overview
Contents
- Malaysian Genomics Resource Centre Berhad Price Chart
- Malaysian Genomics Resource Centre Berhad 0155.KL Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Malaysian Genomics Resource Centre Berhad
- Q&A For Malaysian Genomics Resource Centre Berhad Stock
| Malaysian Genomics Resource Centre Berhad stock price | 0.43 MYR |
| Previous Close | 0.44 MYR |
| Open | 0.44 MYR |
| Bid | 0.44 MYR x N/A |
| Ask | 0.44 MYR x N/A |
| Day's Range | 0.43 - 0.44 MYR |
| 52 Week Range | 0.42 - 1.17 MYR |
| Volume | 297K MYR |
| Avg. Volume | 2.64M MYR |
| Market Cap | 56.64M MYR |
| Beta (5Y Monthly) | 1.380136 |
| PE Ratio (TTM) | 43.5 |
| EPS (TTM) | 0.01 MYR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | December 15, 2021 |
| 1y Target Est | 0.8 MYR |
0155.KL Valuation Measures
| Enterprise Value | 59.14M MYR |
| Trailing P/E | 43.5 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.543125 |
| Price/Book (mrq) | 1.5 |
| Enterprise Value/Revenue | 4.744 |
| Enterprise Value/EBITDA | 189.581 |
Trading Information
Malaysian Genomics Resource Centre Berhad Stock Price History
| Beta (5Y Monthly) | 1.380136 |
| 52-Week Change | -36.029% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.17 MYR |
| 52 Week Low | 0.42 MYR |
| 50-Day Moving Average | 0.54 MYR |
| 200-Day Moving Average | 0.68 MYR |
0155.KL Share Statistics
| Avg. Volume (3 month) | 2.64M MYR |
| Avg. Daily Volume (10-Days) | 776.23K MYR |
| Shares Outstanding | 130.21M |
| Float | 71.9M |
| Short Ratio | N/A |
| % Held by Insiders | 55.57% |
| % Held by Institutions | 4.31% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 6.26% |
| Operating Margin (ttm) | -5.50% |
| Gross Margin | 77.28% |
| EBITDA Margin | 2.50% |
Management Effectiveness
| Return on Assets (ttm) | -1.11% |
| Return on Equity (ttm) | 0.91% |
Income Statement
| Revenue (ttm) | 12.47M MYR |
| Revenue Per Share (ttm) | 0.1 MYR |
| Quarterly Revenue Growth (yoy) | -86.59% |
| Gross Profit (ttm) | 13.85M MYR |
| EBITDA | 311.95K MYR |
| Net Income Avi to Common (ttm) | 780.98K MYR |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.58M MYR |
| Total Cash Per Share (mrq) | 0.03 MYR |
| Total Debt (mrq) | 1.35M MYR |
| Total Debt/Equity (mrq) | 3.45 MYR |
| Current Ratio (mrq) | 16.56 |
| Book Value Per Share (mrq) | 0.29 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20462076 MYR |
| Levered Free Cash Flow (ttm) | -20966566 MYR |
Profile of Malaysian Genomics Resource Centre Berhad
| Country | Malaysia |
| State | N/A |
| City | Petaling Jaya |
| Address | Jalan Teknologi 3/6 |
| ZIP | 47810 |
| Phone | 60 3 7890 0015 |
| Website | https://www.mgrc.com.my |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. The company's services include sequencing and analysis of various human, animal, plant, and microbial genomes. It offers sequencing services, such as whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. The company also provides bioinformatics services, including reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analyzing microRNAs, and analyzing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and trio sequencing services that provide a detailed view of an individual's DNA. In addition, it offers genetic screening and cancer immunotherapy services. Further, the company engages in the business relating to life sciences/cell laboratory and its byproducts; general medical services; and supply of healthcare products and services. Malaysian Genomics Resource Centre Berhad was incorporated in 2004 and is headquartered in Petaling Jaya, Malaysia.
Q&A For Malaysian Genomics Resource Centre Berhad Stock
What is a current 0155.KL stock price?
Malaysian Genomics Resource Centre Berhad 0155.KL stock price today per share is 0.43 MYR.
How to purchase Malaysian Genomics Resource Centre Berhad stock?
You can buy 0155.KL shares on the Kuala Lumpur exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Malaysian Genomics Resource Centre Berhad?
The stock symbol or ticker of Malaysian Genomics Resource Centre Berhad is 0155.KL.
Which industry does the Malaysian Genomics Resource Centre Berhad company belong to?
The Malaysian Genomics Resource Centre Berhad industry is Diagnostics & Research.
How many shares does Malaysian Genomics Resource Centre Berhad have in circulation?
The max supply of Malaysian Genomics Resource Centre Berhad shares is 137.21M.
What is Malaysian Genomics Resource Centre Berhad Price to Earnings Ratio (PE Ratio)?
Malaysian Genomics Resource Centre Berhad PE Ratio is 43.00000000 now.
What was Malaysian Genomics Resource Centre Berhad earnings per share over the trailing 12 months (TTM)?
Malaysian Genomics Resource Centre Berhad EPS is 0.01 MYR over the trailing 12 months.
Which sector does the Malaysian Genomics Resource Centre Berhad company belong to?
The Malaysian Genomics Resource Centre Berhad sector is Healthcare.